<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Oral Health</journal-id><journal-id journal-id-type="iso-abbrev">BMC Oral Health</journal-id><journal-title-group><journal-title>BMC Oral Health</journal-title></journal-title-group><issn pub-type="epub">1472-6831</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26847634</article-id><article-id pub-id-type="pmc">4743192</article-id><article-id pub-id-type="publisher-id">172</article-id><article-id pub-id-type="doi">10.1186/s12903-016-0172-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Kr&#x000fc;ppel-like factor 4 expression in oral carcinoma cells and hypermethylation at the gene promoter</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yamaguchi</surname><given-names>Ayumi</given-names></name><address><email>ayumi.y.ii.may.seven1@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Kuroyama</surname><given-names>Karen</given-names></name><address><email>kyun1096@yahoo.co.jp</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Tokura</surname><given-names>Ayana</given-names></name><address><email>rococo15milktea@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Saito</surname><given-names>Atsushi</given-names></name><address><email>masuzushimango@yahoo.co.jp</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Arikawa</surname><given-names>Huhga</given-names></name><address><email>americanfootboll4223@yahoo.co.jp</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Hasebe</surname><given-names>Takahisa</given-names></name><address><email>soccer.hasebe@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Usui</surname><given-names>Dai</given-names></name><address><email>daiusui1992@yahoo.co.jp</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Yamaguchi</surname><given-names>Kosuke</given-names></name><address><email>kyama@tky.ndu.ac.jp</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Chiba</surname><given-names>Tadashige</given-names></name><address><phone>81.3.3261.8870</phone><email>tchiba@tky.ndu.ac.jp</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Imai</surname><given-names>Kazushi</given-names></name><address><phone>81.3.3261.8857</phone><email>kimai@tky.ndu.ac.jp</email></address><xref ref-type="aff" rid="Aff2"/></contrib><aff id="Aff1"><label/>School of Life Dentistry at Tokyo, The Nippon Dental University, 1-9-20, Chiyoda-ku, Fujimi, Tokyo 102-8159 Japan </aff><aff id="Aff2"><label/>Department of Biochemistry, School of Life Dentistry at Tokyo, The Nippon Dental University, 1-9-20 Chiyoda-ku, Fujimi, Tokyo 102-8159 Japan </aff></contrib-group><pub-date pub-type="epub"><day>4</day><month>2</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>4</day><month>2</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>16</volume><elocation-id>13</elocation-id><history><date date-type="received"><day>29</day><month>10</month><year>2015</year></date><date date-type="accepted"><day>25</day><month>1</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; Yamaguchi et al. 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the json made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Kr&#x000fc;ppel-like factor 4 (KLF4) is a transcription factor regulating proliferation-differentiation balance of epithelium, and down-regulated in less-differentiated and advanced oral carcinomas. Although the expression is inactivated by the promoter hypermethylation in malignant tumor cells, it remains unknown in oral carcinoma cells.</p></sec><sec><title>Methods</title><p>Genomic DNA isolated from nine different oral carcinoma cell lines and a normal keratinocyte line was treated with sodium bisulfite, and methylation at <italic>KLF4</italic> gene promoter was determined by PCR direct-sequence analysis. KLF4 expression in cells cultured with or without demethylation reagent was monitored by quantitative real-time PCR and immunoblot.</p></sec><sec><title>Results</title><p>A 237-bp promoter region spanning&#x02009;&#x02212;&#x02009;718 and&#x02009;&#x02212;&#x02009;482 of <italic>KLF4</italic> gene was hypermethylated in oral carcinoma cells that express <italic>KLF4</italic> at a low level, but the methylation was infrequent in cells expressing <italic>KLF4</italic> high amount. The downstream region from&#x02009;&#x02212;&#x02009;481 to +192 was not methylated in any cell lines. Demethylation treatment of cells up-regulated the expression at mRNA and protein levels.</p></sec><sec><title>Conclusion</title><p>This study demonstrated that hypermethylation at a narrow range of the promoter region down-regulates KLF4 expression, and suggests that the loss of expression by the hypermethylation contributes to oral carcinoma progression.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s12903-016-0172-5) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Gene promoter</kwd><kwd>Hypermethylation</kwd><kwd>Kr&#x000fc;ppel-like factor</kwd><kwd>Oral cancer</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>KAKENHI 26462859</award-id><principal-award-recipient><name><surname>Imai</surname><given-names>Kazushi</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>Oral carcinomas are a most frequent malignant tumor of the head and neck, but the patients&#x02019; prognosis has not been improved sufficiently. Carcinoma cells at invasive front frequently show aberrant gene expression, and dedifferentiate into mesenchymal cell-like states in a process of disease progression [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. In addition, sustained proliferation is another prominent feature in an aggressive subset of carcinomas. Proliferation and differentiation balance of cells control development and homeostasis of epithelium and play a definitive role in pathological state of carcinomas [<xref ref-type="bibr" rid="CR4">4</xref>]. They are largely regulated by tumor suppressive gene, and expression of the genes is frequently inactivated by epigenetic mechanisms [<xref ref-type="bibr" rid="CR5">5</xref>]. It is important to unveil a cause inactivating tumor suppressive gene expression to understand mechanisms of oral carcinoma progression.</p><p>In stratified squamous epithelium including oral epithelium, kr&#x000fc;ppel-like factor (KLF) 4 and 5 are expressed in post-mitotic keratinizing suprabasal cells and proliferative less-differentiated basal cells, respectively. They critically control a proliferation-differentiation balance of the epithelium [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. KLFs transcriptionally regulate target gene expression through binding on the promoter, and previous studies documented that loss of KLF4 expression associates with dedifferentiation of oral carcinoma cells and is frequently observed in an aggressive subset of the carcinomas [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. It suggests an involvement of the loss of expression in carcinoma progression.</p><p>Since chromosomal deletion of <italic>KLF4</italic> gene locus at 9q31.2 is a rare event in carcinomas [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>], epigenetic inactivation of the gene is a prime candidate responsible for the loss of expression. Among epigenetic aberrations found in carcinoma cells, promoter hypermethylation is a most common causative to inactivate gene expression [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. In fact, hypermethylation at <italic>KLF4</italic> gene promoter and enhancer is documented in carcinomas of the colon, stomach, cervix and kidney [<xref ref-type="bibr" rid="CR13">13</xref>&#x02013;<xref ref-type="bibr" rid="CR16">16</xref>]. However, the hypermethylated regions are variably localized in carcinomas of different origin and unknown in oral carcinomas. In this study, we analyzed the hypermethylation and correlation with KLF4 expression in oral carcinoma cells.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Cell lines</title><p>Oral carcinoma cell lines (Ca9.22, Ho-1-u-1, HOC313, HSC2, HSC3, KOSC3, OSC19, SCCKN, TSU) and an immortalized but not transformed normal keratinocyte cell line, HaCaT [<xref ref-type="bibr" rid="CR17">17</xref>], were cultured in 10&#x000a0;% fetal bovine serum-containing medium.</p></sec><sec id="Sec4"><title>Bisulfite-modified sequence analysis of <italic>KLF4</italic> promoter region</title><p>Promoter methylation states at <italic>KLF4</italic> gene were analyzed according to a previous study [<xref ref-type="bibr" rid="CR18">18</xref>]. Genomic DNA isolated from cells were treated with sodium bisulfite and applied for PCR amplification of the promoter region spanning&#x02009;&#x02212;&#x02009;718 and +192 (the transcription start site was set as +1) for direct-sequence analysis. The primer sequences used for the analysis are as follows: 5&#x02019;-<sup>&#x02212;736</sup>GTATGTTAGTAGGGGTG-3&#x02019; (forward), 5&#x02019;-<sup>&#x02212;442</sup>GAGTTTGTTGATTTAGTTGT-3&#x02019; (forward), 5&#x02019;-<sup>&#x02212;331</sup>AAGGAAGTTATAAGTAAGGAA-3&#x02019; (forward), 5&#x02019;-<sup>&#x02212;72</sup>AATAAAACTAACTACC-3&#x02019; (reverse), and 5&#x02019;-<sup>+213</sup>AAACCCAAAACCCCAAATTAA-3&#x02019; (reverse). We referred a DNA sequence json of <italic>KLF4</italic> gene deposited to GenBank (DQ658241.1).</p></sec><sec id="Sec5"><title>Quantitative real-time PCR</title><p>Total RNA isolated form cells with or without 5&#x000a0;&#x003bc;M 5-aza-2-deoxycitidine (5-aza) treatment was reverse transcribed into cDNA by MultiScribe Reverse Transcriptase (Applied Biosystems) and subjected to quantitative real-time PCR using the StepOne Real-time PCR system (Applied Biosystems). PCR conditions were 95&#x000a0;&#x000b0;C for 20&#x000a0;s followed by 40&#x000a0;cycles of 95&#x000a0;&#x000b0;C for 1&#x000a0;s and 60&#x000a0;&#x000b0;C for 20&#x000a0;s. The TaqMan probes specific to <italic>KLF4</italic> (Hs00358836_m1, Applied Biosystems) was used. Expression levels normalized against <italic>ACTB</italic> (TaqMan Endogenous Control Human ACTB, Applied Biosystems) were calculated by the standard curve method (2<sup>-&#x02206;&#x02206;Ct</sup>). To analyze relative-fold of changes of the expression, the expression after the 5-aza treatment was divided by that without treatment.</p></sec><sec id="Sec6"><title>Immunoblot</title><p>Total cell lysates in SDS sample buffer containing 1&#x000a0;mM phenylmethylsulfonyl fluoride and protease inhibitor cocktail (Roche Diagnostic GmbH) was applied to SDS-polyacrylamide gels under the reducing condition, and electrotransferred to PVDF membranes. The membranes were probed with antibodies against KLF4 (Santa Cruz Biotechnology) or &#x003b2;-actin (Sigma-Aldrich) followed by horseradish peroxidase-conjugated secondary antibodies. The signals were detected using Chemi-Lumi One Super (Nakarai Tesque) and captured on Ez-Capture MG (ATTO).</p></sec></sec><sec id="Sec7"><title>Results</title><sec id="Sec8"><title>Expression of KLF4 in oral carcinoma cells</title><p>Expression of <italic>KLF4</italic> mRNA was quantified by the real-time PCR (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Among carcinoma cell lines, it was strongly expressed in HaCaT normal keratinocytes. It was detected at a relatively high level in KOSC2 cells and HOC313 cells, low in HSC2 cells, Ho-1-u-1 cells and Ca9.22 cells, and undetectable in OSC19 cells.<fig id="Fig1"><label>Fig. 1</label><caption><p>Expression of <italic>KLF4</italic> mRNA in oral carcinoma cell lines and normal keratinocytes (HaCaT). <italic>KLF4</italic> expression was quantitatively examined by the real-time PCR. Relative expression was standardized by expression of <italic>ACTB</italic> in each sample (<italic>n</italic>&#x02009;=&#x02009;4) and compared with the expression in HaCaT cells</p></caption><graphic xlink:href="12903_2016_172_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec9"><title>Promoter hypermethylation in carcinoma cells</title><p>Methylation at <italic>KLF4</italic> gene promoter from&#x02009;&#x02212;&#x02009;718 to +192 was examined by the bisulfite-modified PCR direct-sequence analysis. The promoter included 109 methylation-susceptible cytosines (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1), and we described methylation state of each cytosine as U (unmethylated), M (methylated) or U/M (mixture of unmethylation and methylation) in this study. In contrast to the absence of methylation in HaCaT cells, all carcinoma cell lines contained M and/or U/M cytosines and frequency of M cytosine was largely different (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). The methylation was confined in a 237-bp region spanning&#x02009;&#x02212;&#x02009;718 and&#x02009;&#x02212;&#x02009;482 that contains 39 methylation-susceptible cytosines designated as #1 to #39, and the cytosines in 673-bp region downstream of #39 cytosine (#40-#109) was not methylated. Computational analysis indicated that the 237-bp region contains methylation-susceptible cytosines at four Sp1-binding sites (#5, 6, 23, 34 and 38 cytosines) and one PU.1-binding site (#19 cytosine). The #5, 6, 19 and 23 cytosines were frequently methylated in cells that expressed <italic>KLF4</italic> at low level (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref> and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1).<fig id="Fig2"><label>Fig. 2</label><caption><p>Methylation of <italic>KLF4</italic> gene promoter. <bold>a</bold> Position of methylation-susceptible cytosines in the promoter is indicated as blue (<italic>upper line</italic>) and the cytosines are numerically numbered from #1 to #109. Lower lines show cytosines that were entirely methylated (<italic>black</italic>) or unmethylated (<italic>white</italic>) and mixture of methylation and unmethylation (<italic>gray</italic>). M% and U/M% indicate percentage of methylated cytosines and the mixture in 39 cytosines, respectively. <bold>b</bold> Sequence json on #10 and #11 cytosines. Four carcinoma cell lines containing methylated (M) and unmethylated (U) cytosines and the mixture (U/M) were presented as an example</p></caption><graphic xlink:href="12903_2016_172_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Transcription factor binding sites in the 237-bp region. Methylation-susceptible sites are marked by red, and Sp1-binding sites (<italic>blue arrows</italic>) and PU.1-binding site (<italic>green line</italic>) are indicated</p></caption><graphic xlink:href="12903_2016_172_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec10"><title><italic>KLF4</italic> expression after the demethylation</title><p>To examine an involvement of the methylation in KLF4 expression, cells were treated with a demethylation reagent 5-aza and the expression was analyzed at mRNA and protein levels. The treatment strongly increased mRNA expression in TSU cells and especially HSC2 cells (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a</xref>) in which the promoter were hypermethylated extensively. Other cell lines increased the expression variously, excluding OSC19 cells that expressed mRNA below a detectable level. KLF4 protein expression was almost identical to the mRNA expression. It was undetectable in HSC2 cells, HSC3 cells, Ho-1-u-1 cells, TSU cells and OSC19 cells. After the demethylation treatment, hypermethylated HSC2 cells and TSU cells strongly up-regulated the protein expression (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4b</xref>), and Ho-1-u-1 cells, HOC313 cells and Ca9.22 cells that contained no M cytosine did not increase the expression. OSC19 cells did not express the protein like mRNA. Among three cell lines containing both M and U/M cytosines in various rates, HSC3 cells and KOSC2 cells apparently increased the expression but another (SCCKN cells) did not.<fig id="Fig4"><label>Fig. 4</label><caption><p>Expression of KLF4 after the demethylation. <bold>a</bold> Relative fold of <italic>KLF4</italic> mRNA expression in cells treated with 5-aza demethylation reagent divided by the expression without 5-aza treatment (<italic>n</italic> =4). <bold>b</bold> KLF4 protein expression in cells with (+) and without (&#x02212;) 5-aza treatment were examined by immunoblot. &#x003b2;-actin was used as an internal control</p></caption><graphic xlink:href="12903_2016_172_Fig4_HTML" id="MO4"/></fig></p></sec></sec><sec id="Sec11"><title>Discussion</title><p>Carcinoma cells acquire aggressive behaviors in a process of progression by activating and inactivating tumor-associated gene expression. KLF4 expression is decreased in many types of carcinomas in advanced stage and the loss of expression initiates epithelial-mesenchymal transition of carcinoma cells that strongly stimulates the progression [<xref ref-type="bibr" rid="CR19">19</xref>]. In fact KLF4 is down-regulated in less-differentiated and advanced oral carcinomas and suppresses dedifferentiation of the cells [<xref ref-type="bibr" rid="CR7">7</xref>]. Although the promoter hypermethylation is considered as a cause of the loss of expression [<xref ref-type="bibr" rid="CR13">13</xref>&#x02013;<xref ref-type="bibr" rid="CR16">16</xref>], it is not known in oral carcinomas. This study shows that the expression closely correlates with hypermethylation states at a 239&#x000a0;bp-region in the promoter.</p><p>Hypermethylation responsible for gene inactivation is frequently observed in CpG islands of tumor suppressive genes [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>], and it was shown in <italic>KLF4</italic> gene in this study, suggesting that the region is important to regulate KLF4 expression in oral carcinoma cells. This is supported by that demethylation treatment up-regulated KLF4 mRNA and protein in the hypermethylated cells but not the cells without hypermethylation. Ca9.22 cells, Ho-1-u-1 cells and OSC19 cells that were not hypermethylated almost did not increase the expression. It suggests a presence of additional factors to activate the expression. However, it is clear that the hypermethylation is responsible for KLF4 down-regulation, and that the 237&#x000a0;bp-region may play an important role in the expression.</p><p>Hypermethylation of <italic>KLF4</italic> gene is happened at enhancer of the gene in human malignant tumor cells; &#x02212;2,128&#x02009;~&#x02009;&#x02212;1,770 region in medulloblastoma cells [<xref ref-type="bibr" rid="CR20">20</xref>] and&#x02009;&#x02212;&#x02009;1,852&#x02009;~&#x02009;&#x02212;1,658 region in cervical carcinoma cells [<xref ref-type="bibr" rid="CR15">15</xref>]. Although we did not addressed methylation at the enhancer in this study, methylation at promoter region is more directly as a platform to regulate gene expression in general [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Hypermethylation at <italic>KLF4</italic> gene promoter has been observed in gastric carcinoma cells (&#x02212;130&#x02009;~&#x02009;&#x02212;13 region; ref. 14) and in colorectal carcinoma cells (+79&#x02009;~&#x02009;+355 region; ref. 13), but the&#x02009;&#x02212;&#x02009;481&#x02009;~&#x02009;+192 region was not methylated in this study. It indicates that hypermethylation restricted at a 237-bp region from&#x02009;&#x02212;&#x02009;718 to&#x02009;&#x02212;&#x02009;482 is important for the negative regulation in oral carcinoma cells. Recent evidences established that hypermethylation occurs at different region of gene promoter/enhancer in different types of carcinoma cells and the promoter hypermethylation is more designate for cell-lineage and cell-type specification [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. It is plausible that the hypermethylation-sensitive sites in oral carcinoma cells locate apart from other-types of carcinoma cells.</p><p>The 237-bp region encodes Sp1 and PU.1 binding sites that are required for the expression [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Sp1 plays a critical role in epithelial development [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>], and <italic>Klf4</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice develop oral carcinomas [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Therefore, hypermethylation at the 237-bp region appears to have a significant role in KLF4 down-regulation. Since loss of KLF4 expression closely associates with oral carcinoma progression, restoring the expression may be an intriguing strategy to treat the patients.</p></sec><sec id="Sec12"><title>Conclusions</title><p>This study demonstrated that <italic>KLF4</italic> gene promoter was hypermethylated in oral carcinoma cells at a different region from other-types of carcinoma cells, and that it was associated with KLF4 expression. Since KLF4 is tumor suppressive, its inactivation by the promoter hypermthylation may be a mechanism of oral carcinoma progression as in carcinoma cell lines analyzed in this study.</p></sec></body><back><app-group><app id="App1"><sec id="Sec13"><title>Additional file</title><p><media position="anchor" xlink:href="12903_2016_172_MOESM1_ESM.pdf" id="MOESM1"><label>Additional file 1: Figure S1.</label><caption><p> Methylation susceptible sites at <italic>KLF4</italic> gene and the promoter. DNA sequence analyzed in this study is shown (the sequence in exon 1 is capitalized). Cytosines potentially susceptible to methylation and their numerical number were highlighted in red, and a hypermethylated 237-bps region was underlined. <bold>Table S1.</bold> A summary of methylation states at each methylation susceptible cytosine. (PDF 160&#x000a0;kb)</p></caption></media></p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>5-aza</term><def><p>5-aza-2-deoxycitidine</p></def></def-item><def-item><term>KLF</term><def><p>Kr&#x000fc;ppel-like factor</p></def></def-item><def-item><term>M cytosine</term><def><p>Methylated cytosine</p></def></def-item><def-item><term>U cytosine</term><def><p>Unmethylated cytosine</p></def></def-item><def-item><term>U/M cytosine</term><def><p>Mixture of unmethylated and methylated cytosines</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Competing interests</bold></p><p>The authors declare they have no competing interests.</p></fn><fn><p><bold>Authors&#x02019; contribution</bold></p><p>AY, KK, AT, AS, HA, TH, DU, KY and TC completed all experiments. TC and KI designed the study, and KI wrote the manuscript. All authors read and approved the final manuscript.</p></fn></fn-group><ack><title>Acknowledgement</title><p>This study was supported by JSPS KAKENHI Grant Number 26462859, and carried out under a curriculum of Research for Life Dental Science at School of Life Dentistry at Tokyo, The Nippon Dental University.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazawa</surname><given-names>J</given-names></name><name><surname>Mitoro</surname><given-names>A</given-names></name><name><surname>Kawashiri</surname><given-names>S</given-names></name><name><surname>Chada</surname><given-names>KK</given-names></name><name><surname>Imai</surname><given-names>K</given-names></name></person-group><article-title>Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity</article-title><source>Cancer Res</source><year>2004</year><volume>64</volume><issue>6</issue><fpage>2024</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-03-1855</pub-id><pub-id pub-id-type="pmid">15026339</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Soeno</surname><given-names>Y</given-names></name><name><surname>Maeda</surname><given-names>G</given-names></name><name><surname>Taya</surname><given-names>Y</given-names></name><name><surname>Aoba</surname><given-names>T</given-names></name><name><surname>Nasu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Progression of oral squamous cell carcinoma accompanied with reduced E-cadherin expression but not cadherin switch</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><issue>10</issue><fpage>e47899</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0047899</pub-id><pub-id pub-id-type="pmid">23110125</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaya</surname><given-names>K</given-names></name><name><surname>Sudo</surname><given-names>H</given-names></name><name><surname>Maeda</surname><given-names>G</given-names></name><name><surname>Kawashiri</surname><given-names>S</given-names></name><name><surname>Imai</surname><given-names>K</given-names></name></person-group><article-title>Concomitant loss of p120-catenin and &#x003b2;-catenin membrane expression and oral carcinoma progression with E-cadherin reduction</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>8</issue><fpage>e69777</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0069777</pub-id><pub-id pub-id-type="pmid">23936352</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D</given-names></name><name><surname>Weinberg</surname><given-names>RA</given-names></name></person-group><article-title>Hallmarks of cancer: the next generation</article-title><source>Cell</source><year>2011</year><volume>144</volume><issue>5</issue><fpage>646</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id><pub-id pub-id-type="pmid">21376230</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arantes</surname><given-names>LMRB</given-names></name><name><surname>de Carvalho</surname><given-names>AC</given-names></name><name><surname>Melendez</surname><given-names>ME</given-names></name><name><surname>Carvalho</surname><given-names>AL</given-names></name><name><surname>Goloni-Bertollo</surname><given-names>EM</given-names></name></person-group><article-title>Methylation as a biomarker for head and neck cancer</article-title><source>Oral Oncol</source><year>2014</year><volume>50</volume><issue>6</issue><fpage>587</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.oraloncology.2014.02.015</pub-id><pub-id pub-id-type="pmid">24656975</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McConnell</surname><given-names>BB</given-names></name><name><surname>Yang</surname><given-names>WW</given-names></name></person-group><article-title>Mammalian Kr&#x000fc;ppel-like factors in health and diseases</article-title><source>Physiol Rev</source><year>2010</year><volume>90</volume><issue>4</issue><fpage>1337</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1152/physrev.00058.2009</pub-id><pub-id pub-id-type="pmid">20959618</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibata</surname><given-names>M</given-names></name><name><surname>Chiba</surname><given-names>T</given-names></name><name><surname>Matsuoka</surname><given-names>T</given-names></name><name><surname>Mihara</surname><given-names>N</given-names></name><name><surname>Kawashiri</surname><given-names>S</given-names></name><name><surname>Imai</surname><given-names>K</given-names></name></person-group><article-title>Kr&#x000fc;ppel-like factors 4 and 5 expression and their involvement in differentiation of oral carcinomas</article-title><source>Int J Clin Exp Pathol</source><year>2015</year><volume>8</volume><issue>4</issue><fpage>3701</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">26097551</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutkind</surname><given-names>JS</given-names></name><name><surname>Bal De Kier Joffe</surname><given-names>E</given-names></name><name><surname>Calb</surname><given-names>DE</given-names></name><name><surname>Paparella</surname><given-names>ML</given-names></name><name><surname>Alvarez</surname><given-names>R</given-names></name><name><surname>Abrigo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Impairing squamous differentiation by Klf4 deletion is sufficient to initiate tongue carcinoma development upon K-Ras activation in mice</article-title><source>Carcinogenesis</source><year>2014</year><volume>35</volume><issue>3</issue><fpage>662</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgt349</pub-id><pub-id pub-id-type="pmid">24148820</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Mo</surname><given-names>Z</given-names></name><name><surname>Ye</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Jin</surname><given-names>G</given-names></name><etal/></person-group><article-title>Genome-wide association study in Chinese men identified two new prostate cancer risk loci at 9q31.2 and 19q13.4</article-title><source>Nat Genet</source><year>2012</year><volume>44</volume><issue>11</issue><fpage>1231</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1038/ng.2424</pub-id><pub-id pub-id-type="pmid">23023329</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamerdinger</surname><given-names>U</given-names></name><name><surname>Eggermann</surname><given-names>T</given-names></name><name><surname>Schubert</surname><given-names>R</given-names></name><name><surname>Schwanitz</surname><given-names>G</given-names></name><name><surname>Kreiss-Nachtsheim</surname><given-names>M</given-names></name></person-group><article-title>Rare interstitial deletion 9q31.2 to q33.1 de novo: longitudinal study in a patient over a period of more than 20&#x000a0;years</article-title><source>Am J Med Genet A</source><year>2008</year><volume>146A</volume><issue>9</issue><fpage>1180</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.32122</pub-id><pub-id pub-id-type="pmid">18386807</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hackett</surname><given-names>JA</given-names></name><name><surname>Surani</surname><given-names>MA</given-names></name></person-group><article-title>DNA methylation dynamics during the mammalian life cycle</article-title><source>Philos Trans R Soc Lond B Biol Sci</source><year>2013</year><volume>368</volume><issue>1609</issue><fpage>20110328</fpage><pub-id pub-id-type="doi">10.1098/rstb.2011.0328</pub-id><pub-id pub-id-type="pmid">23166392</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boland</surname><given-names>MJ</given-names></name><name><surname>Nazor</surname><given-names>KL</given-names></name><name><surname>Loring</surname><given-names>JF</given-names></name></person-group><article-title>Epigenetic regulation of pluripotency and differentiation</article-title><source>Circ Res</source><year>2014</year><volume>115</volume><issue>2</issue><fpage>311</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.301517</pub-id><pub-id pub-id-type="pmid">24989490</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Hisamuddin</surname><given-names>IM</given-names></name><name><surname>Nandan</surname><given-names>MO</given-names></name><name><surname>Babbin</surname><given-names>BA</given-names></name><name><surname>Lamb</surname><given-names>NE</given-names></name><name><surname>Yang</surname><given-names>VW</given-names></name></person-group><article-title>Identification of Kr&#x000fc;ppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer</article-title><source>Oncogene</source><year>2004</year><volume>23</volume><issue>2</issue><fpage>395</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1207067</pub-id><pub-id pub-id-type="pmid">14724568</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>D</given-names></name><name><surname>Gong</surname><given-names>W</given-names></name><name><surname>Kanai</surname><given-names>M</given-names></name><name><surname>Schlunk</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Yao</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Drastic downregulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression</article-title><source>Cancer Res</source><year>2005</year><volume>65</volume><issue>7</issue><fpage>2746</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-3619</pub-id><pub-id pub-id-type="pmid">15805274</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>WT</given-names></name><name><surname>Zheng</surname><given-names>PS</given-names></name></person-group><article-title>Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>2</issue><fpage>e88827</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0088827</pub-id><pub-id pub-id-type="pmid">24551169</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>W</given-names></name><name><surname>Xia</surname><given-names>D</given-names></name><name><surname>Lang</surname><given-names>B</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name><etal/></person-group><article-title>Epigenetic alterations of Kr&#x000fc;ppel-like factor 4 and its tumor suppressor function in renal cell carcinomas</article-title><source>Carcinogenesis</source><year>2013</year><volume>34</volume><issue>10</issue><fpage>2262</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgt189</pub-id><pub-id pub-id-type="pmid">23722653</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boukamp</surname><given-names>P</given-names></name><name><surname>Pertrussevska</surname><given-names>RT</given-names></name><name><surname>Breitkreutz</surname><given-names>D</given-names></name><name><surname>Hornung</surname><given-names>J</given-names></name><name><surname>Markham</surname><given-names>A</given-names></name><name><surname>Fusenig</surname><given-names>NE</given-names></name></person-group><article-title>Normal keratinization in a spontaneously immortalized aneuploidy human keratinocyte cell line</article-title><source>J Cell Biol</source><year>1998</year><volume>106</volume><issue>3</issue><fpage>761</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1083/jcb.106.3.761</pub-id><pub-id pub-id-type="pmid">2450098</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>G</given-names></name><name><surname>Chiba</surname><given-names>T</given-names></name><name><surname>Kawashiri</surname><given-names>S</given-names></name><name><surname>Satoh</surname><given-names>T</given-names></name><name><surname>Imai</surname><given-names>K</given-names></name></person-group><article-title>Epigenetic inactivation of I&#x003ba;B kinase-&#x003b1; in oral carcinomas and tumor progression</article-title><source>Clin Cancer Res</source><year>2007</year><volume>13</volume><issue>17</issue><fpage>5041</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-07-0463</pub-id><pub-id pub-id-type="pmid">17785555</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yori</surname><given-names>JL</given-names></name><name><surname>Johnson</surname><given-names>E</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Jain</surname><given-names>MK</given-names></name><name><surname>Keri</surname><given-names>RA</given-names></name></person-group><article-title>Kr&#x000fc;ppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><issue>22</issue><fpage>16854</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.114546</pub-id><pub-id pub-id-type="pmid">20356845</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakahara</surname><given-names>Y</given-names></name><name><surname>Northcott</surname><given-names>PA</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Kongkham</surname><given-names>PN</given-names></name><name><surname>Smith</surname><given-names>C</given-names></name><name><surname>Yan</surname><given-names>H</given-names></name><etal/></person-group><article-title>Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma</article-title><source>Neoplasia</source><year>2010</year><volume>12</volume><issue>1</issue><fpage>20</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1593/neo.91122</pub-id><pub-id pub-id-type="pmid">20072650</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahatan</surname><given-names>CS</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name><name><surname>Geiman</surname><given-names>DE</given-names></name><name><surname>Yang</surname><given-names>VW</given-names></name></person-group><article-title>Characterization of the structure and regulation of the murine gene encoding gut-enriched Kr&#x000fc;ppel-like factor (Kr&#x000fc;ppel-like factor 4)</article-title><source>Nucleic Acid Res</source><year>1999</year><volume>27</volume><issue>23</issue><fpage>4562</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1093/nar/27.23.4562</pub-id><pub-id pub-id-type="pmid">10556311</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karpurapu</surname><given-names>M</given-names></name><name><surname>Ranjan</surname><given-names>R</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Chung</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>YG</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><etal/></person-group><article-title>Kr&#x000fc;ppel-like factor 4 promoter undergoes active demethylation during monocyte/macrophage differentiation</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>4</issue><fpage>e93362</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0093362</pub-id><pub-id pub-id-type="pmid">24695324</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paquet</surname><given-names>C</given-names></name><name><surname>Larouche</surname><given-names>D</given-names></name><name><surname>Bisson</surname><given-names>F</given-names></name><name><surname>Proulx</surname><given-names>S</given-names></name><name><surname>Simard-Bisson</surname><given-names>C</given-names></name><name><surname>Gaudreault</surname><given-names>M</given-names></name><etal/></person-group><article-title>Tissue engineering of skin and cornea. Development of new models for in vitro studies</article-title><source>Ann NY Acad Sci</source><year>2010</year><volume>1197</volume><fpage>166</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.05373.x</pub-id><pub-id pub-id-type="pmid">20536846</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaubert</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Segre</surname><given-names>JA</given-names></name></person-group><article-title>Ectopic expression of Kr&#x000fc;ppel-like factor 4 (Klf4) accelerates formation of the epidermal permeability barrier</article-title><source>Development</source><year>2003</year><volume>130</volume><issue>12</issue><fpage>2767</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1242/dev.00477</pub-id><pub-id pub-id-type="pmid">12736219</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">Paparella ML, Abrigo M, Bal de Kier joffe E, Raimondi AR. Oral-specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis. J Oral Pahtol Med. 2015. doi:10.1111/jop.12307.</mixed-citation></ref></ref-list></back></article>